Chronic pain management, Pain management and Pharmaceuticals

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Chronic pain management

Pain management

Pharmaceuticals

Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain

Digital Health Global

JANUARY 29, 2024

As showcased in the ‘ VIRPI ‘ study, ODD-403 marks a statistically significant advancement in chronic pain management. About Orion Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. The core therapy areas of our pharmaceutical R&D are oncology and pain.

Pharmaceuticals

Pharmaceuticals Chronic pain management Digital Health Pain management

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

NOVEMBER 25, 2023

This is due to a number of factors, including: The increasing prevalence of chronic diseases The rising cost of healthcare The increasing demand for patient-centered care As a result, DTx companies are still expected to be attractive targets for M&A deals. The average deal size for DTx M&A deals is increasing.

Pharmaceuticals

Pharmaceuticals Pain management Chronic pain management Mental health

Connected Health Pulse

Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Stay Connected